An unusual Federal Circuit decision has given generic drugmakers a new way to successfully...

Generic Drugmakers Score Big in Rare Federal Circuit Reversal – Bloomberg Law

An unusual Federal Circuit decision has given generic drugmakers a new way to successfully challenge pharmaceutical patents with specific types of claims. Novartis Pharmaceuticals Corp.‘s patent on the dosage regimen for the blockbuster multiple…

 

Read the full article here


-- END RSP MOD -->